FDA Breifing Documents for Regeneron's (REGN) Praluent 'Read Well,' Says RBC Capital
RBC Capital maintained an Outperform on Regeneron Pharma (NASDAQ: REGN). Earlier the FDA posted briefing docs for Regeneron (NASDAQ: REGN) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)